2017
DOI: 10.1016/j.oraloncology.2017.10.023
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the diagnostic efficacy and spectrum of autofluorescence of benign, dysplastic and malignant lesions of the oral cavity using VELscope

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
36
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 47 publications
(39 citation statements)
references
References 39 publications
1
36
0
Order By: Relevance
“…Awan [19] demonstrated the relatively high sensitivity, 84% and a low specificity 15%, in differentiating high-risk lesions from benign lesions. Similarly, Ganga [26] obtained sensitivity and specificity values of 76% and 66.29%, respectively. They suggested that VELscope has reasonable sensitivity, but yields many false-positive results.…”
Section: Introductionmentioning
confidence: 91%
See 1 more Smart Citation
“…Awan [19] demonstrated the relatively high sensitivity, 84% and a low specificity 15%, in differentiating high-risk lesions from benign lesions. Similarly, Ganga [26] obtained sensitivity and specificity values of 76% and 66.29%, respectively. They suggested that VELscope has reasonable sensitivity, but yields many false-positive results.…”
Section: Introductionmentioning
confidence: 91%
“…At these wavelengths, the normal oral mucosa is associated with a pale green fluorescence as viewed through a filter and abnormal tissue is associated with a loss of autofluorescence and appears dark. Many works [19][20][21][22][23][24][25][26] have evaluated the efficacy of the VELscope by direct comparing VELscope results with the biopsy reports. VELscope has been shown to have high sensitivity and to assist in the detection of oral lesions.…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, one such possible diagnosis method involving the application of autofluorescence imaging has been increasingly used. Currently, the VELscope® (LED Dental Inc., Vancouver, Canada; Awan, Morgan, & Warnakulasuriya, ; Ganga et al, ; Hanken et al, ; Huang et al, ; Yamamoto et al, ) and DIFOTI® (Electro‐Optical Sciences Inc., Irvington, NY, USA; Bin‐Shuwaish, Yaman, Dennison, & Neiva, ) systems have been launched for general dental clinics (Lingen, Kalmar, Karrison, & Speight, ). These instruments can detect a decrease or increase in the autofluorescence of flavin adenine dinucleotide (FAD), nicotinamide adenine dinucleotide (NADH), or collagen cross linking, by irradiating the lesional tissue with blue light of a wavelength of 400 to 460 nm (Laronde et al, ; Lingen et al, ).…”
Section: Introductionmentioning
confidence: 99%
“…A number of studies on the autofluorescence imaging method have been concerned with validating the differential diagnosis of OSCC and OPMD, by making comparisons between the FVL of the suspected lesion and cytodiagnosis or biopsy (Awan et al, ; Elvers et al, ; Ganga et al, ; Petruzzi et al, ; Scheer et al, ; Yamamoto et al, ). However, there is currently no standardized numerical cutoff value for assisting in the identification of tumors using such autofluorescence visualization devices.…”
Section: Introductionmentioning
confidence: 99%
“…Commercial devices exploiting skin multispectral reflectance and fluorescence features such as MelaFind, SIAscope, Velscope are suitable for non-invasive cancer diagnostics. However, their insufficient specificity is the main limiting factor for wide clinical implementation in routine clinical praxis [14,15]. Thanks to wide accessibility and rapid development of computing power and the integrated camera image quality, smartphone applications for skin cancer diagnostics is an emerging field of studies [16].…”
Section: Introductionmentioning
confidence: 99%